Nature Communications (Nov 2021)

Serum apolipoprotein A-I potentiates the therapeutic efficacy of lysocin E against Staphylococcus aureus

  • Hiroshi Hamamoto,
  • Suresh Panthee,
  • Atmika Paudel,
  • Kenichi Ishii,
  • Jyunichiro Yasukawa,
  • Jie Su,
  • Atsushi Miyashita,
  • Hiroaki Itoh,
  • Kotaro Tokumoto,
  • Masayuki Inoue,
  • Kazuhisa Sekimizu

DOI
https://doi.org/10.1038/s41467-021-26702-0
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 10

Abstract

Read online

Lysocin E is a lipopeptide with antibiotic activity against methicillin-resistant Staphylococcus aureus. Here, the authors show that the antimicrobial activity of lysocin E is potentiated through interactions with host serum proteins (such as apolipoprotein A-I) and bacterial membrane components.